Assessment of the genotoxic activity of α-asarone and its derivatives in the comet assay

Acta Poloniae Pharmaceutica - Drug Research

Volumn 70, Issue 2, 2013, Pages 349-354

  Marczewska, Jadwiga ^a   Drozd, Ewa ^a   Anuszewska, Elzbieta ^a   Chilmonczyk, Zdzislaw ^a   Lozowicka, Bozena ^b  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b Section of Integrated Modelling   (Poland)

Author keywords

Ames Test; Asarone; Comet Assay; Genotoxicity; Mutagenicity

Indexed keywords

2,3,4 TRIMETHOXYPROPENYLBENZENE; 2,3,6 TRIMETHOXYPROPENYLBENZENE; 2,4,6 TRIMETHOXYPROPENYLBENZENE; 3,4,5 TRIMETHOXYPROPENYLBENZENE; ALPHA ASARONE; ANTILIPEMIC AGENT; BENZENE DERIVATIVE; CELL DNA; DOXORUBICIN; UNCLASSIFIED DRUG;

AMES TEST; ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CELL CULTURE; CELL NUCLEUS; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DNA STRAND BREAKAGE; EVALUATION; FLUORESCENCE MICROSCOPY; GENOTOXICITY; ISOMER; MICRONUCLEUS TEST; MOUSE; MUTAGENIC ACTIVITY; NONHUMAN;

ANIMALS; ANISOLES; COMET ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOLIPIDEMIC AGENTS; ISOMERISM; MICE; MUTAGENS; SALMONELLA TYPHIMURIUM;

EID: 84876742342     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sánchez-Reséndiz J., Lerdo de Tejada A.: J. Ethnopharmacol. 6, 239 (1982).
2. Gómez C., Chamorro G., Chávez M. A., Martinez G., Salazar M., Pages N.: Plantes Med. Phytother. 21, 279 (1987).
3. Chamorro G., Garduno L., Sanchez A., Labarrios F., Salazar M., Martinez E., Diaz F., Tamariz J. : Drug Develop. Res. 43, 105 (1998).
4. Garduno L., Salazar M., Salazar S., Morelos M., Labarrios F., Tamariz J., Chammorro G.: J. Ethnopharmacol. 55, 161 (1997).
5. Rodriguez-Páez L., Juárez-Sanchez M., Antúnez- Solís J., Baeza I., Wong C.: Phytomedicine 10, 397 (2003).
6. Filipek S., Lozowicka B.: Acta Pol. Pharm. Drug Res. 57, 106 (2000).
7. Poplawski J., Lozowicka B., Dubis A., Lachowska B., Witkowski S., Siluk D., Petrusewicz J., Kaliszan. R., Cybulski J., Chilmonczyk Z., Strzalkowska M.: J. Med. Chem. 43, 3671 (2000).
8. Taylor J. M., Jones W. I., Hogan E. C., Gross M. A., David D. A., Cook E. L.: Toxicol. Appl. Pharmacol. 10, 405 (1967).
9. Gross M. A., Jones W. I., Cook E. L., Biine C. C.: Proc. Am. Assoc. Cancer Res. 8, 24 (1967).
10. Salazar M., Salazar S., Ulloa V., Mendoza T., Pages N., Chamoro G.: J. Toxicol. Clin. Exp. 12, 149 (1992).
11. Jimenez L., Chamorro G., Salazar M., Pages N.: Ann. Pharm. Fr. 46, 179 (1988).
12. Chamorro G., Garduno L., Martinez E., Madrigal E., Tamariz J., Salazar M.: Toxicol. Lett. 99, 71 (1998).
13. Morales R. Madrigal B., Mercader M., Cassani M. Gonzalez G., Chamorro G., Salazar M.: Mutat. Res. 279, 269 (1992).
14. Goggelmann W., Schimmer O.: Mutat. Res. 121, 191 (1983).
15. Kim S. G., Liem A., Steward B. C., Miller J. A.: Carcinogenesis 20, 1303 (1999).
16. Karwicka E., Marczewska J., Anuszewska E., Lozowicka B., Chilmonczyk Z.: Bioorg. Med. Chem. 16, 6069 (2008).
17. Ostling O., Johanson J.: Biochem. Biophys. Res. Commun. 123, 291 (1984).
18. Singh N. P., McCoy M. C., Tice R. R., Schneider E. L.: Exp. Cell Res. 175, 184 (1988
19. Maron D. M., Ames B. N.: Mutat. Res. 113, 173 (1983).
20. Ejchart A., Chlopkiewicz B.: Biul. IL 45, 765 (2001).
21. Anuszewska E., Chlopkiewicz B., Gruber B., Marczewska J., Priebe W., Skurzak H.: Acta Pol. Pharm. Drug Res, 63, 321 (2006).
22. Kevekordes S., Spielberger J., Burghaus C. M., Birkenkamp P., Zietz B., Paufler P., Diez, M., Bolten C., Dunkelberg H.: Anticancer Res. 21, 461 (2001).
23. Kevekordes, S., Mersch-Sundermann V., Burghaus Ch. M., Spilberger J., Schmeiser H. H., Arlt V. M., Dunkelberg H.: Mutat. Res. 445, 81 (1999).